Publications by authors named "Yooksil Sin"

Claim this Profile
P
Polyplex Nanomicelle-Mediated Pgc-1α4 mRNA Delivery Via Hydrodynamic Limb Vein Injection Enhances Damage Resistance in Duchenne Muscular Dystrophy Mice.
Xuan Du, Hideyuki Nakanishi, Takashi Yamada, Yooksil Sin, Katsura Minegishi

Adv Sci (Weinh)· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Establishment and characterization of two novel patient-derived cell lines from giant cell tumor of bone: NCC-GCTB8-C1 and NCC-GCTB9-C1.
Yuki Adachi, Rei Noguchi, Yuki Yoshimatsu, Yooksil Sin, Julia Osaki

Hum Cell· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Establishment and characterization of NCC-PMP2-C1: a novel patient-derived cell line of pseudomyxoma peritonei with signet ring cells.
Rei Noguchi, Yuki Yoshimatsu, Yooksil Sin, Takuya Ono, Ryuto Tsuchiya

Hum Cell· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Establishment and characterization of NCC-LMS3-C1: a novel patient-derived cell line of leiomyosarcoma.
Yuki Yoshimatsu, Rei Noguchi, Julia Osaki, Yooksil Sin, Ryuto Tsuchiya

Hum Cell· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Establishment and characterization of NCC-DFSP4-C1: a novel cell line from a patient with dermatofibrosarcoma protuberans having the fibrosarcomatous transformation.
Taro Akiyama, Yuki Yoshimatsu, Rei Noguchi, Yooksil Sin, Julia Osaki

Hum Cell· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Establishment and characterization of two novel patient-derived cell lines from giant cell tumor of bone.
Takuya Ono, Rei Noguchi, Yuki Yoshimatsu, Yooksil Sin, Ryuto Tsuchiya

Hum Cell· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Noguchi et al. Establishment and Characterization of NCC-PMP1-C1: A Novel Patient-Derived Cell Line of Metastatic Pseudomyxoma Peritonei. 2022, , 258.
Rei Noguchi, Yuki Yoshimatsu, Yooksil Sin, Takuya Ono, Ryuto Tsuchiya

J Pers Med· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrating analysis of proteome profile and drug screening identifies therapeutic potential of MET pathway for the treatment of malignant peripheral nerve sheath tumor.
Ryuto Tsuchiya, Yuki Yoshimatsu, Rei Noguchi, Yooksil Sin, Takuya Ono

Expert Rev Proteomics· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Establishment and characterization of NCC-DSM1-C1: a novel cell line derived from a patient with desmoid fibromatosis.
Taro Akiyama, Yuki Yoshimatsu, Rei Noguchi, Yooksil Sin, Julia Osaki

Hum Cell· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Establishment and characterization of NCC-MRT1-C1: a novel cell line of malignant rhabdoid tumor.
Taro Akiyama, Yuki Yoshimatsu, Rei Noguchi, Yooksil Sin, Ryuto Tsuchiya

Hum Cell· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Establishment and characterization of NCC-GCTB5-C1: a novel cell line of giant cell tumor of bone.
Taro Akiyama, Yuki Yoshimatsu, Rei Noguchi, Yooksil Sin, Ryuto Tsuchiya

Hum Cell· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Establishment and characterization of NCC-PLPS2-C1: a novel cell line of pleomorphic liposarcoma.
Taro Akiyama, Yuki Yoshimatsu, Rei Noguchi, Yooksil Sin, Julia Osaki

Hum Cell· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Establishment and characterization of NCC-MRT1-C1: a novel cell line of malignant rhabdoid tumor.
Taro Akiyama, Yuki Yoshimatsu, Rei Noguchi, Yooksil Sin, Ryuto Tsuchiya

Hum Cell· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Establishment and characterization of NCC-MFS6-C1: a novel patient-derived cell line of myxofibrosarcoma.
Yuki Yoshimatsu, Rei Noguchi, Yooksil Sin, Ryuto Tsuchiya, Takuya Ono

Hum Cell· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Establishment and characterization of NCC-PS1-C1: a novel cell line of pleomorphic sarcoma from a patient after neoadjuvant radiotherapy.
Taro Akiyama, Yuki Yoshimatsu, Rei Noguchi, Yooksil Sin, Ryuto Tsuchiya

Hum Cell· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Establishment and characterization of NCC-GCTB5-C1: a novel cell line of giant cell tumor of bone.
Taro Akiyama, Yuki Yoshimatsu, Rei Noguchi, Yooksil Sin, Ryuto Tsuchiya

Hum Cell· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Establishment and characterization of a novel patient-derived Ewing sarcoma cell line, NCC-ES2-C1.
Yuki Yoshimatsu, Rei Noguchi, Yooksil Sin, Ryuto Tsuchiya, Takuya Ono

Hum Cell· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Establishment and characterization of a novel patient-derived cell line of dedifferentiated liposarcoma, NCC-DDLPS6-C1.
Yuki Yoshimatsu, Rei Noguchi, Yooksil Sin, Ryuto Tsuchiya, Takuya Ono

Hum Cell· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Establishment and characterization of two novel patient-derived myxoid liposarcoma cell lines.
Rei Noguchi, Yuki Yoshimatsu, Yooksil Sin, Ryuto Tsuchiya, Takuya Ono

Hum Cell· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Establishment and characterization of NCC-SS5-C1: a novel patient-derived cell line of synovial sarcoma.
Yuki Yoshimatsu, Rei Noguchi, Yooksil Sin, Ryuto Tsuchiya, Takuya Ono

Hum Cell· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Establishment and characterization of NCC-DDLPS5-C1: a novel patient-derived cell line of dedifferentiated liposarcoma.
Yooksil Sin, Yuki Yoshimatsu, Rei Noguchi, Ryuto Tsuchiya, Takuya Ono

Hum Cell· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Establishment and characterization of NCC-UPS4-C1: a novel cell line of undifferentiated pleomorphic sarcoma from a patient with Li-Fraumeni syndrome.
Takuya Ono, Yuki Yoshimatsu, Rei Noguchi, Yooksil Sin, Ryuto Tsuchiya

Hum Cell· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Establishment and Characterization of NCC-PMP1-C1: A Novel Patient-Derived Cell Line of Metastatic Pseudomyxoma Peritonei.
Rei Noguchi, Yuki Yoshimatsu, Yooksil Sin, Takuya Ono, Ryuto Tsuchiya

J Pers Med· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Establishment and Characterization of NCC-MFS5-C1: A Novel Patient-Derived Cell Line of Myxofibrosarcoma.
Ryuto Tsuchiya, Yuki Yoshimatsu, Rei Noguchi, Yooksil Sin, Takuya Ono

Cells· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Establishment and Characterization of NCC-DDLPS4-C1: A Novel Patient-Derived Cell Line of Dedifferentiated Liposarcoma.
Ryuto Tsuchiya, Yuki Yoshimatsu, Rei Noguchi, Yooksil Sin, Takuya Ono

J Pers Med· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis